这是演示店铺,请务下单付款,避免造成你的财物损失。

为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

Avelumab (anti-PD-L1)

功能和特点
  • 规格或纯度: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
  • 应用: ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)
  • 反应种属: Cynomolgus,Dog ,Human,Mouse ,Rabbit ,Rat 
  • 亚型: Human IgG1
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
A412006-1mg
1mg 现货 Stock Image
A412006-5mg
5mg 现货 Stock Image
A412006-10mg
10mg 期货 Stock Image

基本信息

产品名称 Avelumab (anti-PD-L1)
别名 阿维单抗; 阿维鲁单抗; Recombinant Avelumab Antibody; Avelumab; Anti-Human PD-L1, Human Antibody; Anti-PD-L1; MSB0010718C; Bavencio; B7 H antibody; B7 H1 antibody; B7 homolog 1 antibody; B7-H1 antibody; B7H antibody; B7H1 antibody; CD 274 antibody; CD-274 antibody;
英文别名 Recombinant Avelumab Antibody; Avelumab; Anti-Human PD-L1, Human Antibody; Anti-PD-L1; MSB0010718C; Bavencio; B7 H antibody; B7 H1 antibody; B7 homolog 1 antibody; B7-H1 antibody; B7H antibody; B7H1 antibody; CD 274 antibody; CD-274 antibody; CD274 antibo
规格或纯度 Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
特异性 B7-H1 / PD-L1 / CD274
应用 ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)
反应种属 Cynomolgus,Dog ,Human,Mouse ,Rabbit ,Rat 

产品属性

抗体类型 Primary antibody
Format Whole IgG
亚型 Human IgG1
轻链亚型 Lambda
SDS-PAGE 28.7 kDa (Light Chain) & 50.1 kDa (Heavy Chain), under reducing conditions; 182.4 kDa, under non-reducing conditions.
纯化方法 Protein A purified
来源 CHO supernatant
物理外观 Liquid
储存缓冲液 Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 Lot by Lot
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 Store at -80℃ for 18 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS编号和信息 1537032-82-8

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

图片

Avelumab (anti-PD-L1) (A412006) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood lymphocytes labelling PD-L1 with Avelumab (anti-PD-L1) (A412006) conjugated with biotin (right panel) compared with Human IgG (Ab170213) conjugated with biotin - Isotype Control (left panel) and detected with SA-PE (rp156250).

Avelumab (anti-PD-L1) (A412006) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood lymphocytes labelling PD-L1 (red) with Avelumab (anti-PD-L1) (A412006) conjugated with biotin and detected with SA-PE (rp156250). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.

Avelumab (anti-PD-L1) (A412006) - SEC
The purity of Avelumab (anti-PD-L1) (A412006) is more than 95% verified by HPLC.

产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Pardoll DM.  (2012)  The blockade of immune checkpoints in cancer immunotherapy..  Nat Rev Cancer,  12  (4):  (252-64).  [PMID:22437870]
2. Topalian SL, Drake CG, Pardoll DM.  (2015)  Immune checkpoint blockade: a common denominator approach to cancer therapy..  Cancer Cell,  27  (4):  (450-61).  [PMID:25858804]

计算器